Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure.
Publication
, Journal Article
Felker, GM; O'connor, CM
Published in: Am Heart J
December 2001
Duke Scholars
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
December 2001
Volume
142
Issue
6
Start / End Page
932 / 933
Location
United States
Related Subject Headings
- Treatment Outcome
- Research Design
- Hypotension
- Humans
- Hemodynamics
- Heart Transplantation
- Heart Failure
- Cost-Benefit Analysis
- Clinical Trials as Topic
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Felker, G. M., & O’connor, C. M. (2001). Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure. Am Heart J, 142(6), 932–933. https://doi.org/10.1067/mhj.2001.119611
Felker, G. M., and C. M. O’connor. “Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure.” Am Heart J 142, no. 6 (December 2001): 932–33. https://doi.org/10.1067/mhj.2001.119611.
Felker GM, O’connor CM. Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure. Am Heart J. 2001 Dec;142(6):932–3.
Felker, G. M., and C. M. O’connor. “Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure.” Am Heart J, vol. 142, no. 6, Dec. 2001, pp. 932–33. Pubmed, doi:10.1067/mhj.2001.119611.
Felker GM, O’connor CM. Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure. Am Heart J. 2001 Dec;142(6):932–933.
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
December 2001
Volume
142
Issue
6
Start / End Page
932 / 933
Location
United States
Related Subject Headings
- Treatment Outcome
- Research Design
- Hypotension
- Humans
- Hemodynamics
- Heart Transplantation
- Heart Failure
- Cost-Benefit Analysis
- Clinical Trials as Topic
- Cardiovascular System & Hematology